You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Acarbose

Showing 1 - 25 of 146
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tolerance, Side Effect, Glucose Response Trial in Ann Arbor (Acarbose Tablets 50mg)

Active, not recruiting
  • Tolerance
  • +2 more
  • Acarbose Tablets 50mg
  • Ann Arbor, Michigan
    AgelessRx
Sep 14, 2022

Type 2 Diabetes, Blood Glucose Fluctuation Trial in Nanjing (Metformin plus pioglitazone, Acarbose)

Recruiting
  • Type 2 Diabetes
  • Blood Glucose Fluctuation
  • Metformin plus pioglitazone
  • Acarbose
  • Nanjing, China
    Nanjing First Hospital, Nanjing Medical Univesity
Nov 28, 2022

Kidney Cancer Trial in Birmingham (Acarbose Tablets)

Not yet recruiting
  • Kidney Cancer
  • Acarbose Tablets
  • Birmingham, Alabama
    University of Alabama at Birmingham
Aug 2, 2022

Learn More About How Acarbose and Metformin Work When Taken

Recruiting
  • Type 2 Diabetes Mellitus
  • BAY81-9783 (Acarbose/Metformin)
  • Multiple Locations, India
    Many locations
Aug 10, 2022

Overweight or Obesity Trial in Linköping, Solna, Uppsala, (EMP16-120/40, MR orlistat 120 mg, Conventional orlistat 120 mg,)

Recruiting
  • Overweight or Obesity
  • Linköping, Sweden
  • +2 more
Jun 28, 2023

Aging Trial in Bronx (Acarbose, Placebo)

Completed
  • Aging
  • Acarbose
  • Placebo
  • Bronx, New York
    Montefiore Medical Center
Jan 20, 2022

Type 2 Diabetes Trial in China (Alogliptin, Acarbose, Metformin)

Completed
  • Type 2 Diabetes Mellitus
  • China, China
    CHINA
Apr 18, 2022

Type 2 Diabetes Trial in Nanjing (sitagliptin and acarbose)

Completed
  • Type 2 Diabetes
  • sitagliptin and acarbose
  • Nanjing, China
    Gu Gao
Aug 30, 2021

Overweight or Obesity Trial in Linköping, Uppsala (EMP16-02 120 mg orlistat/40 mg acarbose, EMP16-02 150 mg orlistat/50 mg

Completed
  • Overweight or Obesity
  • EMP16-02 120 mg orlistat/40 mg acarbose
  • +2 more
  • Linköping, Sweden
  • +1 more
Apr 1, 2022

Other Specified Hypotension, Syncope Trial in Vancouver (Acarbose, Placebo)

Completed
  • Other Specified Hypotension
  • Syncope
  • Acarbose
  • Placebo
  • Vancouver, British Columbia, Canada
    Vancouver Coastal Health Research Institute, VGH Research Pavili
May 26, 2021

Healthy Volunteers Trial in Corvallis (Acarbose)

Recruiting
  • Healthy Volunteers
  • Acarbose
  • Corvallis, Oregon
    Department of Food Science and Technology
Apr 18, 2022

Type 2 Diabetes Trial in China (Dapagliflozin, Acarbose)

Terminated
  • Type 2 Diabetes Mellitus
  • Beijing, China
  • +19 more
Nov 23, 2021

Polycystic Ovary Syndrome Trial in Sherbrooke (Rosiglitazone, Acarbose)

Completed
  • Polycystic Ovary Syndrome
  • Sherbrooke, Quebec, Canada
    Université de Sherbrooke
Jan 4, 2022

Pancreatitis, Chronic, Exocrine Pancreatic Insufficiency, Abdominal Pain Trial in Shanghai (extracorporeal shock wave

Recruiting
  • Pancreatitis, Chronic
  • +3 more
  • extracorporeal shock wave lithotripsy and endoscopic drainage of the main pancreatic duct
  • pancreatic enzyme(Pancreatin Enteric-coated Capsules or Oryz-Aspergillus Enzyme and Pancreatin Table), antidiabetic medicine(Acarbose Tablets, Glucophage, Glimepirde Tablets)
  • Shanghai, China
    Changhai Hospital
Feb 26, 2022

Type 2 Diabetes Trial in China (INSULIN GLARGINE (HOE901), Insulin Glulisine, Biphasic insulin aspart 30)

Completed
  • Type 2 Diabetes Mellitus
  • INSULIN GLARGINE (HOE901)
  • +5 more
  • China, China
    CHINA
Apr 21, 2022

Type 2 Diabetes Trial in Seoul (Acarbose, Placebo acarbose, metformin)

Completed
Has Results
  • Type 2 Diabetes Mellitus
  • Acarbose
  • +2 more
  • Seoul, Korea, Republic of
    MedicalExcellence
Jul 31, 2020

Diabetes, Type 2 Trial in Shanghai (Acarbose/Metformin FDC(BAY81-9783), Glucobay, Glucophage)

Completed
  • Diabetes Mellitus, Type 2
  • Acarbose/Metformin FDC(BAY81-9783)
  • +2 more
  • Shanghai, China
    Zhongshan Hospital, Fudan University
Apr 10, 2020

Type 2 Diabetes Trial in Hamilton (drug, behavioral, other)

Completed
Has Results
  • Type 2 Diabetes Mellitus
  • insulin glargine
  • +4 more
  • Hamilton, Ontario, Canada
    McMaster University Medical Centre, Diabetes Care and Research P
May 10, 2020

Overweight or Obesity Trial in Uppsala (Xenical® vs EMP 22, EMP 22 vs Xenical®, EMP 16 vs Xenical®)

Not yet recruiting
  • Overweight or Obesity
  • Xenical® vs EMP 22
  • +2 more
  • Uppsala, Sweden
    CTC Clinical Trial Consultanta AB
Aug 25, 2023

Diabetes, Type 2 Trial in China (Acarbose, Metformin, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Acarbose
  • +2 more
  • Hefei, Anhui, China
  • +28 more
Aug 3, 2020

Dietary Supplement Trial in Tustin, Singapore (Dietary Supplement: Sprinkled Format REDUCOSE., Reference control, Active

Completed
  • Dietary Supplement
  • Dietary Supplement: Sprinkled Format REDUCOSE.
  • +2 more
  • Tustin, California
  • +1 more
Feb 2, 2022

Type2 Diabetes Trial in Beijing (Glucophage 500Mg Tablet, Acarbose Tablets, Sitagliptin tablet)

Unknown status
  • Type2 Diabetes Mellitus
  • Glucophage 500Mg Tablet
  • +5 more
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Feb 26, 2020

Glucose Metabolism Disorders Trial in Hellerup (Acarbose, Placebo Oral Tablet, Exendin (9-39))

Completed
  • Glucose Metabolism Disorders
  • Acarbose
  • +3 more
  • Hellerup, Denmark
    Center for Diabetesresearch
Mar 25, 2020

Aging Trial in San Antonio (acarbose)

Completed
Has Results
  • Aging
  • acarbose
  • San Antonio, Texas
    UTHSCSA
Feb 21, 2019

Type 2 Diabetes, Obesity, Cognitive Impairment Trial in Nanjing (Liraglutid, Dapagliflozin, Acarbose)

Unknown status
  • Type 2 Diabetes Mellitus
  • +2 more
  • Nanjing, Jiangsu, China
    at Division of Endocrinology, the Affiliated Drum Tower Hospital
May 22, 2019